Skip to content
Search

Latest Stories

Follow Us:
Top Stories

Amid Confusing CDC Guidance About Vaccines, Study Highlights New Risk of COVID-19 During Pregnancy

A Harvard study found that the children of women who contracted COVID-19 while pregnant may be at an increased risk for autism and other diagnoses, raising new concerns about the CDC’s decision to stop recommending the vaccine to pregnant women.

News

A nurse giving a patient a shot.

A pregnant woman receives a COVID-19 vaccine at a pharmacy in Pennsylvania in 2021. Hannah Beier/Reuters.

Hannah Beier/Reuters

In the first 18 months of the COVID-19 pandemic, tens of thousands of pregnant women were wheeled into hospitals where they fought for their lives and the lives of the babies they carried.

It took the Centers for Disease Control and Prevention until August 2021, eight months after the first vaccine was administered, to formally recommend the COVID-19 shot for pregnant and breastfeeding mothers. The CDC had found that pregnant women with COVID-19 faced a 70% increased risk of dying, compared with those who weren’t. They also faced an increased risk of being admitted to the intensive care unit, needing a form of life support reserved for the sickest patients, and delivering a stillborn baby. In recommending the vaccine, the CDC assured them that the shot was safe and did not cause fertility problems.


ProPublica examined the harm caused by the delay in rolling out and endorsing the vaccine for pregnant mothers. Federal officials at the time told us that they wanted to ensure “an abundance of evidence” before issuing guidance.

But a surprising turn of events this summer reversed that guidance.

In May, Robert F. Kennedy Jr., the Health and Human Services secretary and a longtime vaccine critic, announced on X that “the COVID vaccine for healthy children and healthy pregnant women has been removed from @CDCgov recommended immunization schedule. Bottom line: it’s common sense and it’s good science. We are now one step closer to realizing @POTUS’s promise to Make America Healthy Again.”

The next month, Kennedy fired all 17 sitting members of the CDC’s Advisory Committee on Immunization Practices and replaced them with a selection of hand-picked members. The committee has since shifted its guidance, encouraging people to decide on their own whether to get the shot and to consider individual risk factors.

Doctors and national medical organizations said the new guidance from the CDC has caused confusion among patients and could put pregnant women and their babies at risk of severe illness or hospitalization.

“COVID-19 infection during pregnancy increases the risk of preterm birth, preeclampsia, and stillbirth,” read a statement from the Society for Maternal-Fetal Medicine.

The organization, as well as the American College of Obstetricians and Gynecologists, the nation’s leading professional organization for OB-GYNs, reiterated their recommendations that all those who are pregnant or breastfeeding receive the updated vaccine and booster, regardless of the trimester they’re in.

ProPublica found that though unvaccinated women faced devastating risks, the COVID-19 vaccine had been commandeered by disinformation and doubt. Pharmaceutical companies and government officials had not ensured that pregnant women were included in the early development of the vaccine, despite federal guidance on how to safely include pregnant and breastfeeding people in biomedical research.

The HHS’ communications director, Andrew G. Nixon, defended the federal government’s actions, saying in a statement: “ACIP’s recommendation applies to all individuals six months and older. It includes an emphasis that the risk-benefit of vaccination in individuals under age 65 is most favorable for those who are at an increased risk for severe COVID-19 and lowest for individuals who are not at an increased risk, according to the CDC list of COVID-19 risk factors.”

Pregnancy is listed as a condition that can increase risk.

In the midst of the backlash against the CDC’s guidance, a recent Harvard University study highlights a new risk of COVID-19 during pregnancy. In a rare look at the children of women who contracted COVID-19 while pregnant, the study found that they may be at increased risk for autism and other neurodevelopmental diagnoses by age 3.

Researchers, who followed the children via their medical records from birth through their toddler years, observed some initial developmental delays at 12 months and again around 18 months, said Dr. Andrea Edlow, one of the study’s senior authors and an OB-GYN at Harvard Medical School.

“We were seeing speech and motor delays, but we really didn’t know if they were going to be persistent or evolve into other diagnoses like autism, or if children were maybe going to catch up,” Edlow said. “But that, unfortunately, hasn’t been the case.”

Edlow treated many pregnant patients during the pandemic, including some who experienced a life-threatening condition known as a cytokine storm. They often had high fevers and severe inflammation for several days. The condition, she remembers thinking, couldn’t be good for the placenta or the developing fetal brain.

Edlow and her team studied more than 18,000 live births to mothers who delivered between March 2020 and May 2021. Of those, more than 800 had been diagnosed with COVID-19. What surprised them was that 16.3% of those babies received a neurodevelopmental diagnosis by three years, compared with 9.7% of the babies who were not exposed to COVID-19 in utero. That was a statistically significant finding. During the period covered by the study, the CDC had not yet come out with its formal recommendation for pregnant women to get the COVID-19 vaccine, and as such, most of the mothers were unvaccinated.

The children of mothers who contracted COVID-19 in the third trimester, a critical time for fetal brain development, and boys had an even higher risk. The male placenta and fetal brain, the researchers wrote, are more susceptible to a mother’s immune response to COVID-19 and other infections.

“I know it’s alarming,” Edlow said.

The researchers, she said, are not out to stoke fear. While the risk of autism is increased, Edlow said, the overall risk still remains low. The study underscores the importance of monitoring children born to mothers who had COVID-19 while pregnant for neurodevelopmental conditions.

Edlow encouraged pregnant women to do everything they can to avoid getting COVID-19, including wearing masks, avoiding crowded indoor spaces and getting vaccinated and boosted.

“COVID is a real problem that poses risk to the mom in pregnancy and to the child,” she said. “And it’s still worth preventing, even at this point.”

Dr. Naima Joseph worries about how the reversal of the COVID-19 vaccine recommendation for pregnant patients will affect the health of the country, particularly its most vulnerable residents, women and children.

She remembers standing in line during the pandemic to get her COVID-19 vaccine when her husband, who is also a doctor, turned to her.

“Are you sure you should be doing this?” he asked.

Joseph, a maternal fetal medicine doctor at Boston Medical Center who serves on ACOG’s Immunization, Infectious Disease, and Public Health Preparedness Expert Work Group, paused. She was pregnant with twins. Like so many mothers, what she cared about most in this world was protecting her babies, but she also treated many pregnant patients sick with COVID-19 who spent months fighting for their lives from a hospital bed. Some died or lost their babies.

“Yes,” she replied to her husband before getting the shot.


Amid Confusing CDC Guidance About Vaccines, Study Highlights New Risk of COVID-19 During Pregnancy was originally published by ProPublica and is republished with permission.


Read More

Pregnant woman holding her belly during a prenatal exam.

Americans are questioning whether they have enough resources and support to raise a family in the nation's current political landscape. Julie Roland examines the contradictions of "pro-family" politics in America today and the kind of care mothers are owed to safely and successfully raise children.

Getty Images, Drs Producoes

The Trump Administration Has a Mommy Problem

My mother, who died of breast cancer when I was 18, had me when she was 32. This past Sunday, I turned 33, childless. As I officially fall behind her timeline, with no plans to have kids anytime soon, I look at the landscape of 2026 America and have to ask: Who can blame me?

The decision to start a family is a difficult one. J.D. Vance said on his first day as Vice President that he wants “more babies in America,” but many Americans simply can’t afford to have kids anymore. Perhaps that’s one reason why this administration is offering $5,000 “baby bonuses” just to incentivize birth, while also banning abortion in every way they can. But becoming a mother should be a choice. I was the result of an unplanned pregnancy–and I’m lucky my mom decided to have me and that she turned out to be the best mom ever–but as Miriam Rabkin, MD, MPH, put it: “if you want mom to be happy and healthy, she needs access to contraception so she can choose if and when to get pregnant!” Instead, this administration seems to think that if women won’t elect to have children, they should try paying them, and if that doesn’t work, then they should just force them.

Keep ReadingShow less
‘Women Will Die’: How the Mifepristone Ban Will Affect Women across the Country

In this photo illustration, packages of Mifepristone tablets are displayed at a family planning clinic.

(Photo illustration by Anna Moneymaker/Getty Images)

‘Women Will Die’: How the Mifepristone Ban Will Affect Women across the Country

WASHINGTON–Maternal health advocates and a Virginia state legislator warned that women’s health would suffer even in states that allow abortions if the Supreme Court fails to block a ban on mail deliveries of mifepristone, a drug used in abortions.

Jennifer McClellan, a representative for the state of Virginia and long-time advocate for reproductive rights, experienced a high-risk pregnancy and an emergency C-section 9 weeks before her due date. She said that she worried about the risks to individuals if they lose easy access to Mifepristone for abortions, miscarriages, or other reasons.

Keep ReadingShow less
stethoscope and us dollar bills on blue-colored background.

As debate over universal health care intensifies in the United States, rising medical costs, insurance complexity, and international comparisons are fueling renewed calls for a transparent, accountable system that guarantees basic care for all Americans.

Getty Images, aaaaimages

The United States May Be the Best Place to Build Universal Health Care

The debate over health insurance in the United States has returned to the forefront as the Affordable Care Act faces political pressure, insurance premiums continue to climb, and physicians experience increasing restrictions from insurance companies. A recent poll shows that roughly 62 to 68 percent of Americans believe the government has a responsibility to ensure health care coverage for all. Yet after more than a century of debate, the federal government has taken only small steps toward universal coverage. Today, the United States spends a relatively high amount per person on health care, but Americans die younger and are less healthy than residents in other high-income countries.

Having experienced different health care systems firsthand, I am deeply aware of how universal health care can impact life. Surprisingly, I have also realized that the United States may actually have one of the systems best suited to making it work.

Keep ReadingShow less
Reduce Barriers That Delay Care
a doctor holding a stethoscope
Photo by Nappy on Unsplash

Reduce Barriers That Delay Care

Today, administrative complexity continues to shape access to care, affecting both patients and providers. For individuals seeking timely treatment, delays and uncertainty remain common. For providers — especially community and rural hospitals — the burden of navigating these processes continues to strain already limited resources.

Prior authorization requirements are one of the most visible examples of this dynamic, and a 11% reduction in such reviews over the last year following an insurance industry pledge offers a welcome sign of progress. At a minimum, this shift suggests that some of the administrative burden embedded in the system can be reduced without compromising its core functions. But it also underscores a more persistent issue.

Keep ReadingShow less